MARIA JUAREZ-CARDENAS: Open Payments
NPI 1952028557 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 32 payments from 13 companies in 2025. Trend: 2023 $272 · 2024 $15 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $280 |
| PFIZER INC. | 3 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| ABIOMED | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
Products named: KRYSTEXXA, OTEZLA, MOUNJARO, Kerendia, BREZTRI, CAPLYTA, ELIQUIS, JOURNAVX.
Industry payments across NV — which companies pay providers there.
